384TiPEffectiveness of olaparib plus trastuzumab in...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

384TiPEffectiveness of olaparib plus trastuzumab in HER2[+], BRCA–mutated (BRCAm) or homologous recombination deficient (HRD) advanced breast cancer (ABC) patients (pts). The OPHELIA study

Alés-Martínez, J E, Morales, S, Fernández Abad, M, Sánchez-Rovira, P, Salvador Bofill, F J, Lahuerta, A, García-Sáenz, J A, Garau Llinas, I, Díaz Redondo, T, Ferrer, N, Carañana, V, López, R, Alonso S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.079
Date:
October, 2019
File:
PDF, 99 KB
2019
Conversion to is in progress
Conversion to is failed